vs
Side-by-side financial comparison of DUOS TECHNOLOGIES GROUP, INC. (DUOT) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
Spero Therapeutics, Inc. is the larger business by last-quarter revenue ($12.6M vs $9.5M, roughly 1.3× DUOS TECHNOLOGIES GROUP, INC.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs -33.8%, a 284.5% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 547.5%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 149.0%).
DUOS Technologies Group Inc. develops and deploys AI-powered automation, inspection, and security solutions for railway transportation, critical infrastructure, and commercial clients across North America. Its offerings include real-time monitoring systems and safety tools that help customers boost efficiency, reduce risks, and strengthen site security.
DUOT vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.5M | $12.6M |
| Net Profit | $-3.2M | $31.5M |
| Gross Margin | 26.7% | — |
| Operating Margin | -36.1% | — |
| Net Margin | -33.8% | 250.7% |
| Revenue YoY | 547.5% | 24080.8% |
| Net Profit YoY | 6.1% | 250.9% |
| EPS (diluted) | $-0.10 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.5M | $12.6M | ||
| Q3 25 | $6.9M | $0 | ||
| Q2 25 | $5.7M | $0 | ||
| Q1 25 | $5.0M | $12.0K | ||
| Q4 24 | $1.5M | $52.0K | ||
| Q3 24 | $3.2M | $65.0K | ||
| Q2 24 | $1.5M | $114.0K | ||
| Q1 24 | — | $140.0K |
| Q4 25 | $-3.2M | $31.5M | ||
| Q3 25 | $-1.0M | $-7.4M | ||
| Q2 25 | $-3.5M | $-1.7M | ||
| Q1 25 | $-2.1M | $-13.9M | ||
| Q4 24 | $-3.4M | — | ||
| Q3 24 | $-1.4M | $-17.1M | ||
| Q2 24 | $-3.2M | $-17.9M | ||
| Q1 24 | — | $-12.7M |
| Q4 25 | 26.7% | — | ||
| Q3 25 | 36.6% | — | ||
| Q2 25 | 26.5% | — | ||
| Q1 25 | 26.5% | — | ||
| Q4 24 | -22.6% | — | ||
| Q3 24 | 28.4% | — | ||
| Q2 24 | -14.2% | — | ||
| Q1 24 | — | — |
| Q4 25 | -36.1% | — | ||
| Q3 25 | -16.2% | — | ||
| Q2 25 | -60.0% | — | ||
| Q1 25 | -36.1% | -122758.3% | ||
| Q4 24 | -211.2% | — | ||
| Q3 24 | -59.3% | -28604.6% | ||
| Q2 24 | -212.9% | -16720.2% | ||
| Q1 24 | — | -9987.1% |
| Q4 25 | -33.8% | 250.7% | ||
| Q3 25 | -15.1% | — | ||
| Q2 25 | -61.3% | — | ||
| Q1 25 | -42.0% | -115550.0% | ||
| Q4 24 | -233.2% | — | ||
| Q3 24 | -43.3% | -26380.0% | ||
| Q2 24 | -212.1% | -15668.4% | ||
| Q1 24 | — | -9049.3% |
| Q4 25 | $-0.10 | $0.56 | ||
| Q3 25 | $-0.06 | $-0.13 | ||
| Q2 25 | $-0.30 | $-0.03 | ||
| Q1 25 | $-0.18 | $-0.25 | ||
| Q4 24 | $-0.40 | — | ||
| Q3 24 | $-0.18 | $-0.32 | ||
| Q2 24 | $-0.43 | $-0.33 | ||
| Q1 24 | — | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $48.6M | $59.0M |
| Total Assets | $63.4M | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $40.3M | ||
| Q3 25 | — | $48.6M | ||
| Q2 25 | — | $31.2M | ||
| Q1 25 | — | $48.9M | ||
| Q4 24 | — | $52.9M | ||
| Q3 24 | $613.6K | $76.3M | ||
| Q2 24 | — | $63.5M | ||
| Q1 24 | — | $82.3M |
| Q4 25 | $48.6M | $59.0M | ||
| Q3 25 | $49.5M | $26.5M | ||
| Q2 25 | $4.7M | $32.8M | ||
| Q1 25 | $5.2M | $33.8M | ||
| Q4 24 | $2.3M | $46.1M | ||
| Q3 24 | $2.5M | $65.5M | ||
| Q2 24 | $2.9M | $80.5M | ||
| Q1 24 | — | $96.2M |
| Q4 25 | $63.4M | $68.9M | ||
| Q3 25 | $69.8M | $54.2M | ||
| Q2 25 | $31.1M | $62.1M | ||
| Q1 25 | $34.1M | $77.7M | ||
| Q4 24 | $35.0M | $110.5M | ||
| Q3 24 | $22.0M | $135.2M | ||
| Q2 24 | $21.2M | $149.9M | ||
| Q1 24 | — | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.7M | $-8.4M |
| Free Cash FlowOCF − Capex | $-18.6M | — |
| FCF MarginFCF / Revenue | -196.3% | — |
| Capex IntensityCapex / Revenue | 167.6% | — |
| Cash ConversionOCF / Net Profit | — | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $-37.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.7M | $-8.4M | ||
| Q3 25 | $-3.2M | $17.4M | ||
| Q2 25 | $-3.2M | $-17.7M | ||
| Q1 25 | $-4.7M | $-4.0M | ||
| Q4 24 | $2.7M | $-23.4M | ||
| Q3 24 | $-2.3M | $12.8M | ||
| Q2 24 | $-1.9M | $-18.7M | ||
| Q1 24 | — | $5.9M |
| Q4 25 | $-18.6M | — | ||
| Q3 25 | $-9.6M | — | ||
| Q2 25 | $-4.0M | — | ||
| Q1 25 | $-5.2M | — | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | $-2.9M | — | ||
| Q2 24 | $-2.8M | — | ||
| Q1 24 | — | — |
| Q4 25 | -196.3% | — | ||
| Q3 25 | -139.7% | — | ||
| Q2 25 | -69.6% | — | ||
| Q1 25 | -105.9% | — | ||
| Q4 24 | 166.2% | — | ||
| Q3 24 | -90.2% | — | ||
| Q2 24 | -184.3% | — | ||
| Q1 24 | — | — |
| Q4 25 | 167.6% | — | ||
| Q3 25 | 93.8% | — | ||
| Q2 25 | 13.8% | — | ||
| Q1 25 | 11.6% | — | ||
| Q4 24 | 19.5% | — | ||
| Q3 24 | 20.5% | — | ||
| Q2 24 | 58.0% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -0.26× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DUOT
| Services And Consulting Related Parties | $8.5M | 90% |
| Other | $929.3K | 10% |
SPRO
Segment breakdown not available.
